Diabetic Nephropathy Market Information: By Diagnosis (Urine Test, Blood Test), By Treatment (Medications, Kidney Dialysis, Transplant), By Indication (Diabetes 1, Diabetes 2), By End User (Hospital & Clinic, Surgical Centers) â Global Forecast Till 2023Â Diabetic nephropathy, known as diabetic kidney disease (DKD), is a kidney malady frequently found in patients with type 1 and type 2 diabetes.
The global diabetic nephropathy market report by Market Research Future (MRFR) provides a quantitative and qualitative analysis by listing out trends, factors, and restraints with ample figures and statistics to back up the evidence.Market OutlookThe global Diabetic Nephropathy Market Size is expected to reach a mammoth valuation by exhibiting 5.2% CAGR from 2018 to 2023 (forecast period).
Immense demand for diagnostic and imaging tests such as kidney biopsy, blood test, urine test, CT scan, and MRI scans can fuel the market demand.
According to the World Health Organization, patients with chronic diseases touched a high of 35 million globally.
The expansion of the healthcare sector and availability of these tests at reputed hospitals and clinics can lend credibility to the trend.
Angiotensin converting enzyme inhibitors (ACEi) have been known to have moderate success in clinical trials with placebo treatment in reducing the risk of death in patients with diabetes.But high costs of these imaging tests can pose a challenge to the market growth.Browse Complete Report :https://www.marketresearchfuture.com/reports/diabetic-nephropathy-market-5664Segmentation Analysis The global diabetic nephropathy market is segmented by diagnosis, treatment, indication, and end-user.By diagnosis, it is segmented into imaging tests, urine tests, blood tests, renal function testing, and kidney biopsy.